NEW YORK, Feb. 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
IVD Procedure Volume and Pricing Analysis
This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes.. Point of Care (Glucose, Pregnancy, Other)
- CoreLab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune)
- Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other)
- Hematology
- Coagulation (PT, PTT)
- Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media)
- Blood Banking
- Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)
For each of these categories., Global procedure volume estimates are provided for the historic 2012 period and forecasts are provided through 2017. Price estimates are offered for leading products, systems and equipment; these represent average list prices but do not take into account variations between countries, discounts or rebates and other fluctuations. Pricing trend analysis is provided for each category. Basic sales estimates for each major market segment are provided. The report also provides
- Fees earned by test providers across categories, 2012-2017
- Regional Analysis of IVD market drivers
- Fees Earned by Largest Clinical Laboratories
- Cancer, Infectious Disease, Microbial Resistance and Other Import Trends
- Description of IVD Tests in Clinical Use.
- CLIA Registered Labs by Facility 2012
Clinical laboratory medicine plays an integral role in healthcare and disease management, as it estimated that approximately 80% of physician's diagnoses are a result of laboratory tests. In addition to disease diagnosis, clinical lab testing is also performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. The increase in lab procedure volumes across categories of tests, as well as the corresponding increase in fees earned and instruments and reagents sold, points to the increasing importance of testing to the healthcare system. The global market for in vitro diagnostics (IVD) and clinical lab tests remains strong, with a plethora of new products and rising procedure volumes through 2017. Furthermore, clinical lab testing is poised to increase dramatically in the developing nations and even developed economies like China as the healthcare infrastructure in these countries improves and the standard of care is uniformly raised across their populations. This, combined with the introduction of new tests and technologies in the developed world will drive strong global growth through the foreseeable future. Which company is performing what share of IVD procedures? This unique business planning tool answers this question, allowing readers to obtain procedure volume by company. The following IVD leaders are profiled and their procedure volume is analyzed in this report:
- Abbott Laboratories
- ALERE
- Arkray
- Beckman Coulter, Inc./Danaher
- Becton, Dickinson & Co.
- BioMerieux, Inc.
- Bio-RAD Laboratories, Inc.
- Bio-Reference Laboratories
- Clarient, Inc./GE Healthcare 1
- Danaher Corp.
- DaVita, Inc.
- Genoptix, Inc./Novartis
- Gen-Probe, Inc.
- Hologic, Inc.
- Horiba Medical
- Instrumentation Laboratory
- Laboratory Corporation of America
- Myriad Genetics
- Ortho Clinical Diagnostics
- Qiagen
- Quest Diagnostics
- Radiometer A/S
- Roche
- Siemens
- Spectra Laboratories
- Sysmex Corp.
- Thermo Fisher Scientific
CHAPTER ONE: EXECUTIVE SUMMARY
The Global IVD and Lab Tests Market
Scope and Methodology
Size and Growth of the Market
Market Trends
CHAPTER TWO: INTRODUCTION
Types of Tests
Venues for Test Usage
Hospitals
Physicians
Independent Clinical Laboratories
Population and Disease Demographics
World Population
Life Expectancy
Disease Incidence and Prevalence
Cancer
Diabetes
Antimicrobial Drug Resistance
Regional Market Characteristics and Trends
United States
Europe
Japan
BRIC Nations
China
Other Countries
CHAPTER THREE: POINT OF CARE TEST PROCEDURE VOLUMES
Overview
Types of Tests
OTC Tests
Pregnancy/Ovulation Tests
Professional Tests
Glucose Tests
Tests for Infectious Disease
Critical Care Tests
Other Tests
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
CHAPTER FOUR: CORE LABORATORY TEST PROCEDURE VOLUMES
Overview
Types of Tests
Clinical Chemistries
Immunoassays
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
CHAPTER FIVE : MOLECULAR TEST PROCEDURE VOLUMES
Overview
Types of Tests
Infectious Disease
Oncology
Inherited Disease
Other
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
CHAPTER SIX: HEMATOLOGY TEST PROCEDURE VOLUMES
Overview
Types of Tests
Leading Products and Prices
Global Sales
Global Procedure Volume
Pricing Trends
Procedure Volume Trends
CHAPTER SEVEN: COAGULATION TEST PROCEDURE VOLUMES
Overview
Types of Tests
Leading Products and Prices
Global Sales
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
CHAPTER EIGHT: MICROBIOLOGY PROCEDURE VOLUMES
Overview
Types of Tests
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
CHAPTER NINE: BLOOD BANKING TESTS PROCEDURE VOLUMES
Overview
Types of Tests
Leading Products and Prices
Global Sales
Global Procedure Volume
Pricing Trends
Procedure Volume Trends
CHAPTER TEN: HISTOLOGY AND CYTOLOGY PROCEDURE VOLUMES
Overview
Types of Tests
Immunohistochemistry and In Situ Hybridization
Circulating Tumor Cells
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
CHAPTER ELEVEN: COMPANY PROFILES AND PROCEDURE VOLUME ANALYSIS
Introduction
Abbott Laboratories
Overview
IVD/Lab Test Market Participation
ALERE
Procedure Volume Share
Financial Snapshot
Arkray
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Beckman Coulter, Inc./Danaher
Overview
IVD/Lab Test Market Participation
Financial Snapshot
Becton, Dickinson & Co
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
BioMerieux, Inc.
Overview
IVD/Lab Test Market Participation
Bio-RAD Laboratories, Inc.
Overview
IVD/Lab Test Market Participation
Bio-Reference Laboratories
Overview
IVD/Lab Test Market Participation
Clarient, Inc./GE Healthcare
Overview
IVD/Lab Test Market Participation
Financial Snapshot
Danaher Corp.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
DaVita, Inc.
Overview
IVD/Lab Test Market Participation
Financial Snapshot
Genoptix, Inc./Novartis
Overview
IVD/Lab Test Market Participation
Financial Snapshot
Gen-Probe, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Hologic, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Horiba Medical
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Instrumentation Laboratory
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Laboratory Corporation of America
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Myriad Genetics
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Ortho Clinical Diagnostics
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Qiagen
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Quest Diagnostics
Procedure Volume Share
Radiometer A/S
Overview
IVD/Lab Test Market Participation
Financial Snapshot
Roche
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Siemens
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Spectra Laboratories
Overview
IVD/Lab Test Market Participation
Financial Snapshot
Sysmex Corp.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Thermo Fisher Scientific
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Global IVD and Clinical Lab Sales, 2012 – 2017
Table 1-2: Global IVD and Clinical Lab Procedure Fees Earned by Market Segment(POC, CoreLab, Molecular, Hematology, Coagulation, Microbiology, Blood Banking,Histology/Cytology) 2012 – 2017
Figure 1-1: Global IVD and Clinical Lab Procedure Fees by Market Segment(thousands)
Table 1-3: Global IVD and Clinical Lab Unit Test Prices by Market Segment (POC, CoreLab, Molecular, Hematology, Coagulation, Microbiology, Blood Banking,Histology/Cytology) in $, 2012 – 2017
Table 1-4: Global IVD and Clinical Lab Procedure Volumes by Market Segment (POC,CoreLab, Molecular, Hematology, Coagulation, Microbiology, Blood Banking,Histology/Cytology), 2012 – 2017
Figure 1-2: Global IVD and Clinical Lab Procedure Volumes by Market Segment2012-2017
CHAPTER TWO: INTRODUCTION
Table 2-1: Types of IVD and Clinical Laboratory Tests
Table 2-2: CLIA-Registered Laboratories by Type of Facility, June 2011
Table 2-3: Global Population, 1980 – 2020
Table 2-4: U.S. Population, 1980 – 2020
Table 2-5: Selected Global Disease Statistics, January 2013
Exhibit 2-1: Global IVD and Clinical Lab Market, 2012
CHAPTER THREE: POINT OF CARE TEST PROCEDURE VOLUMES
Table 3-1: Selected POC Tests and Prices, 2012
Table 3-2: Global POC Test Sales by Test Type in $Million, 2012 – 2017
Table 3-3: Global POC Test Procedure Volume by Test Type in Millions, (Glucose, Pregnancy/Ovulation, Other OTC, Professional Glucose, Infectious Disease, Critical Care, Other POC) 2012 – 2017
CHAPTER FOUR: CORE LABORATORY TEST PROCEDURE VOLUMES
Table 4-1: Selected Core Lab Tests and Prices, 2012
Table 4-2: Global Core Lab Test Sales, 2012 – 2017
Table 4-3: Global Core Lab Test Procedure Volume by Test Type
(General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays
Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune),2012 – 2017
CHAPTER FIVE: MOLECULAR ASSAYS
Table 5-1: Selected Molecular Assay Test Services and Prices, 2012
Table 5-2: Global Molecular Assay Sales in $Million, 2012 – 2017
Table 5-3: Global Molecular Assay Procedure Volume by Test Type
(Infectious Disease, Oncology, Inherited Disease, Other), 2012 – 2017
Table 5-4: Global Infectious Disease Molecular Assay Procedure Volume by Test Type(HIV, Hepatitis, GC/Chlamydia, HAI, Respiratory, Others), 2012 – 2017
CHAPTER SIX: HEMATOLOGY TEST PROCEDURE VOLUMES
Table 6-1: Selected Hematology Analyzers and Prices, 2012
Table 6-2: Global Hematology Analyzer Sales in $Million, 2012 – 2017
Table 6-3: Global Lab-Based Hematology Test Procedure Volume in Millions, 2012 – 2017
CHAPTER SEVEN: COAGULATION TEST PROCEDURE VOLUMES
Table 7-1: Selected Coagulation Analyzers and Prices, 2012
Table 7-2: Global Coagulation Analyzer Sales in $Million, 2012 – 2017
Table 7-3: Global Lab-Based Coagulation Test Procedure Volume by Test Type (PT, PTT) 2012 – 2017
CHAPTER EIGHT: MICROBIOLOGY PROCEDURE VOLUMES
Table 8-1: Selected Lab-Based ID/AST Microbiology Instruments and Prices, 2012
Table 8-2: Global Lab-Based ID/AST Microbiology Instrument Sales, 2012 – 2017
Table 8-3: Global Lab-Based ID/AST Microbiology Procedure Volume by Test Type (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media) in Millions, 2012 – 2017
CHAPTER NINE: BLOOD BANKING TESTS PROCEDURE VOLUMES
Table 9-1: Selected Blood Grouping Products and Prices, 2012
Table 9-2: Global Blood Grouping Product Sales, 2012 – 2017
Table 9-3: Global Blood Grouping Procedure Volume in $Million, 2012 – 2017
CHAPTER TEN: HISTOLOGY AND CYTOLOGY PROCEDURE VOLUMES 109
Table 10-1: Selected Histology/Cytology Products and Prices, 2012
Table 10-2: Global Histology/Cytology Sales, 2012 – 2017
Table 10-3: Global Histology/Cytology Procedure Volume by Test Type (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs) 2012 – 2017
CHAPTER ELEVEN: PROFILES OF KEY PLAYERS
Table 11-1: Global Sales and Procedure Volumes of the Leading Manufacturers of
IVD and Clinical Lab Products and Equipment, 2012
Figure 11-1: Global Sales and Procedure Volume Share of the Leading Manufacturers of IVD and Clinical Lab Products and Equipment, 2012
Table 11-2: Global Procedure Fees of the Leading Clinical Laboratories, 2012
Figure 11-2: Procedure Fee Share of the Leading Clinical Laboratories, 2012
Table 11-3: Abbott Laboratories Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-4: Abbott Laboratories Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-5: Alere Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-6: Alere Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-7: Arkray Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-8: Arkray Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-9: Beckman Coulter Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-10: Beckman Coulter Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-11: Becton Dickinson Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-12: Becton Dickinson Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-13: BioMerieux Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-14: BioMerieux Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-15: Bio-Rad Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-16: Bio-Rad Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-17: Bio-Reference Laboratories Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-18: Bio-Reference Laboratories Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-19: Clarient Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-20: Clarient Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-21: Danaher Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-22: Danaher Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-23: DaVita Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-24: DaVita Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-25: Genoptix Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-26: Genoptix Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-27: Gen-Probe Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-28: Gen-Probe Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-29: Hologic Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-30: Hologic Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-31: Horiba Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-32:: Horiba Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-33: Instrumentation Laboratory Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-34: Instrumentation Laboratory Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-35: Labcorp Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-36: Labcorp Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-37: Myriad Genetics Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-38: Myriad Genetics Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-39: Ortho Clinical Diagnostics Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-40: Ortho Clinical Diagnostics Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-41: Qiagen Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-42: Qiagen Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-43: Quest Diagnostics Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-44: Quest Diagnostics Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-45: Radiometer A/S Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-46: Radiometer A/S Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-47: Roche Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-48: Roche Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-49: Siemens Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-50: Roche Estimated Global IVD and Clinical Lab Sales by Market Segment , 2012
Table 11-51: Spectra Laboratories Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-52: Spectra Laboratories Estimated Global IVD and Clinical Lab Procedure Fees by Market Segment, 2012
Table 11-53: Sysmex Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-54: Sysmex Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
Table 11-55: Thermo Fisher Scientific Estimated Global IVD and Clinical Lab Procedure Volume by Market Segment, 2012
Table 11-56: Thermo Fisher Scientific Estimated Global IVD and Clinical Lab Sales by Market Segment, 2012
COMPANY DIRECTORY
To order this report:
In_Vitro_Diagnostic Industry: IVD Procedure Volume and Pricing Analysis
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article